Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
p38α, also known as MAPK14, is a serine/threonine protein kinase and a member of the mitogen-activated protein kinase (MAPK) family. It plays central roles in cellular responses to stress, inflammatory signaling, cell survival/apoptosis, proliferation/differentiation/migration, and mRNA stability. It is activated by dual phosphorylation at the TGY motif by upstream kinases. p38α has complex roles in disease, acting as a tumor suppressor during early tumorigenesis but potentially promoting tumor progression at later stages or under certain conditions. Current inhibitors often lack selectivity, posing a challenge for therapeutic development.
Inhibition of p38α kinase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on p38 mitogen-activated protein kinase alpha (p38α).